Companies and organizations from Medtronic to the state of California are deploying AI to improve workflows and outcomes.

Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.

The Galien Foundation recently announced the nominees for its "Best Medical Technology" Pix Galien USA awards.

Medtronic's product portfolio is comprised of a variety of life-saving and life-improving medical devices that include implantable defibrillators, heart valves, insulin pumps, glucose monitoring ...

Medtronic has been consistently growing ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's ...

Investor expectations from medical device makers ... glucose monitor (CGM), Simplera. It also announced a partnership under which Abbott's CGM system will connect to Medtronic's automated insulin ...

MINNEAPOLIS — Seventy-five years ago, Medtronic, the world’s largest medical device company ... Their new continuous glucose monitor, he says, is getting very close to mimicking a healthy ...

Medtronic CTO outlines how AI is empowering doctors and helping deliver better outcomes for patients. It’s not hyperbole to ...

The FDA recently announced it appointed Ross Segan as the new Director of the Office of Product Evaluation and Quality (OPEQ) ...

The Medtronic GI Genius™ system demonstrates AI's capacity to improve diagnostic accuracy by serving as a second set of eyes for clinicians, demonstrating 99.7%-100% sensitivity rate when screening ...

Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00.

At its current valuation, DexCom stock is the opposite of a bargain. Even after its big drop over the summer, it would still be a risky stock to buy now. Those who are interested would probably do ...